Buscar resultados de ensayos clínicos
Peritoneal Neoplasms - 29 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: An Observational Study of Avastin (Bevacizumab) in Combination With Carboplatin/Paclitaxel in First Line in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (OTILIA) Condición: Peritoneal Neoplasms Fecha: 2012-09-28 |
Completed |
Nombre del estudio: Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers Condición: Peritoneal Neoplasms Fecha: 2008-04-23 Intervenciones: Drug: nanoparticulate paclitaxel This is a Phase 1, dose-escalation study with 6 cohorts of 1 - 6 patien |
Active, not recruiting |
Nombre del estudio: Quality of Life Study for Pediatric and Adult Patients Undergoing Hyperthermic Peritoneal Perfusion With Cisplatin Condición: Peritoneal Neoplasms Fecha: 2007-07-16 Intervenciones: Behavioral: Questionnaire QOL Questionnaires taking a total of 10 minutes to complete. |
Terminated |
Nombre del estudio: A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis Condición: Peritoneal Neoplasms Fecha: 2006-07-14 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: BOVARI: A Non-Interventional Study of Avastin (Bevacizumab) as Front-Line Treatment in Patients With Ovarian Cancer Condición: Ovarian Cancer, Peritoneal Neoplasms Fecha: 2013-02-08 |
Withdrawn |
Nombre del estudio: Comparison of Traditional and Echocardiography Guided Fluid Management During Cytoreductive Surgery With HIPEC Condición:
|
Completed |
Nombre del estudio: Goal Directed Therapy (GDT) in Cytoreductive Surgery (CRS) and Hyperthermic Intra Peritoneal Chemotherapy (Hipec) Condición:
|
Not yet recruiting |
Nombre del estudio: An Observational Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer Condición: Ovarian Cancer, Peritoneal Neoplasms Fecha: 2013-08-27 |
Terminated |
Nombre del estudio: A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer Condición:
Fecha: 2007-08-14 Intervenciones: Drug: Volociximab 15 mg/kg weekly, IV infusions, for 8 weeks or until disease progression or unacceptabl |
Completed |
Nombre del estudio: Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis Condición:
Fecha: 1999-11-03 Intervenciones:
|